The heterotetrameric adaptor complexes 1 and 2 (AP1 and AP2) play integral roles in clathrin-mediated membrane trafficking. The precise orchestration of AP1 and AP2 assembly requires the chaperone protein alpha and gamma adaptin-binding protein (AAGAB). Despite its recognized importance, the intricate molecular mechanisms governing AAGAB's facilitation of AP1 and AP2 assembly remain elusive. Using in vitro reconstitution and X-ray crystallography, we discovered that, before AP1/AP2 binding, AAGAB exists as a homodimer. AAGAB dimerization is mediated by its highly conserved C-terminal domain (CTD), which is critical for AAGAB stability. At the onset of AP complex assembly, AAGAB utilizes its CTD to form a 1:1 complex with either the AP1γ subunit or the AP2α subunit, thus stabilizing the γ and α subunits. Similarly, the highly conserved N-terminal G domain (GD) in AAGAB recognizes and stabilizes AP1 and AP2 σ subunits, facilitating their recruitment onto the respective AP1γ and AP2α subunits to form crucial AP1γ:σ and AP2α:σ assembly intermediates. Collectively, our investigation demonstrates a dual role of AAGAB in stabilizing individual AP subunits and promoting the formation of assembly intermediates. Furthermore, our findings offer a molecular insight into the pathogenesis of specific skin diseases, such as punctate palmoplantar keratoderma type 1 (PPKP1), where a notable absence of the CTD is observed in many patients. This work was supported by NIH grants GM138685 (Q.Y.), AI146330 (Q.Y.), GM126960 (J.S.), DK124431 (J.S.), and AI156560 (S.L.).
No takes yet. Share an insight, caveat, or question.
Yang et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: